Could Bristol-Myers Squibb Be a Multibagger?

Investor Chuck Akre recently shared his secret to stock success with a group of Fools: He simply looks for 100-baggers. After we politely snickered, Chuck explained that while he hasn't actually found a 100-bagger yet, he does believe that companies that can compound shareholder capital at high rates have the best chance of generating phenomenal returns over the long haul.

As you'll see below, Bristol-Myers Squibb (NYSE: BMY  ) generates incredible returns on equity (ROE). While we don't know whether it could be a 100-bagger over time, we can use the DuPont ROE formula to learn how Bristol-Myers Squibb generates those incredible returns on equity.

Company

ROE

Net Margin

Asset Turnover

Leverage

Bristol-Myers Squibb

71.6%

55%

0.64

2.04

sanofi-aventis (NYSE: SNY  )

11.7%

19.2%

0.36

1.68

Watson Pharmaceuticals (NYSE: WPI  )

9.7%

8.2%

0.66

1.78

Source: Capital IQ, a division of Standard & Poor's.

With higher margins than Sanofi and Watson Pharmaceuticals, Bristol-Myers Squibb clearly outshines the competition. The DuPont formula, broken out in the table above, shows that Bristol-Myers Squibb uses its consumer advantage -- high margins, low asset turnover, and reasonable leverage -- to generate very attractive returns on equity for shareholders.

The Foolish bottom line
I thought Chuck was a little crazy to pursue only 100-baggers. Then again, perhaps he's crazy like a fox. If a company like Bristol-Myers Squibb can generate incredible returns on equity over time, the market will likely pay higher and higher prices for a piece of its greatness. True, we might have to settle for a two- or three-bagger, instead of a 100-bagger ... but maybe that was Chuck's point all along.

In true Warren Buffett (or Chuck Akre) fashion, the guys at Motley Fool Inside Value love to find companies with durable competitive advantages. Discover everything they've turned up so far with a 30-day free trial.

Million Dollar Portfolio associate advisor David Meier does not own shares of any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (14)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1279288, ~/Articles/ArticleHandler.aspx, 8/23/2014 2:46:45 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Apple's next smart device (warning, it may shock you

Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early-in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!


Advertisement